Lewy body disease is a stealthy and relentless brain disorder that affects memory, movement, and core body functions. It ...

The myasthenia gravis (MG) market across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and the ...

Cite this: Acetylcholinesterase Inhibitors (AChEI's) for the Treatment of Visual Hallucinations in Schizophrenia: A Review of the Literature - Medscape - Sep 01, 2010.

Aricept (donepezil) is a prescription drug used to treat dementia related to Alzheimer’s disease. Aricept belongs to a class of drugs called acetylcholinesterase inhibitors. It is not an ...

An acetylcholinesterase inhibitor isolated from Corydalis tuber and its mode of action. Korean J Pharmacogn 27: 91-95. Ingkaninan K, Temkitthawon P, Chuenchom K, Yuyaem T, Thongnoi W 2003. Screening ...

Acetylcholinesterase Inhibitors . The acetylcholinesterase inhibitor drug class consists of several medications. The list includes: Donepezil; Rivastigmine; Galantamine; Zunveyl (benzgalantamine) The ...

Zunveyl ® (benzgalantamine) is now available for the treatment of mild to moderate dementia of the Alzheimer type in adults.. The active ingredient in Zunveyl is benzgalantamine, a prodrug of ...

Use of donepezil (Aricept), an acetylcholinesterase inhibitor, for 3 weeks failed to demonstrate efficacy in treating fatigue and psychological symptoms of long COVID in a randomized trial from Japan.

Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor (FcRn) inhibitors, offer a new treatment paradigm, though challenges remain.

The following is a summary of “Efficacy of acetylcholinesterase inhibitors on reducing hippocampal atrophy rate: a systematic review and meta-analysis,” published in the February 2025 issue of BMC ...

ZUNVEYL is a next generation acetylcholinesterase inhibitor approved in the US for the treatment of mild-to-moderate Alzheimer’s disease. Terms of the agreement total $44 million, ...